Abstract
Infectious complications of pancreatic cysts (PC) is one of the problem of modern medicine due to insufficient data on pharmacokinetic of majority of antimicrobials resulting to the lack of standards for antimicrobial therapy and prophylaxis of this disorder. One of the promising options for the treatment and prophylaxis of PC-associated infections is moxifloxacin, but there is no data available on its pharmacokinetic in PC. Twenty eight PK samples and 27 serum samples from 27 patients with PK cysts were included in the study. Samples were obtained 3 hours after 400 mg IV dose of moxifloxacin. Drug concentrations were measured using reversed-phase high performance liquid chromatography. All calculations were done using Millennium v2.1 software. Moxifloxacin concentrations in PCs were 0.04–1.98 mg/l (mean±SD = 0.57±0.41). Corresponding serum concentrations were 0.86-2.45 mg/l (mean ± SD = 1.67±0.39). In general, PC concentrations of moxifloxacin were lower than serum concentrations, but still higher than MICs for majority of bacterial pathogens. Moreover, no bacterial growth was detected in all PC samples and no clinical signs of infections were registered. Thus, it can be concluded that moxifloxacin may be an interesting option for the therapy and prophylaxis of PC-associated infections.
-
1.
Borman P.C., Beckingham I.J., Chronic pancreatitis. BMJ 2001; 322:660-3.
-
2.
Dunkin B.J., Ponsky J.L., Hale J.C. Ultrasound-direct percutaneous endoscopic cyst-gastrostomy for the treatment of a pancreatic pseudocyst. Surg Endosc 1998; 12:1426-9.
-
3.
Maringhini A., Uomo R., Patti R., Rabitty P., Termini A., Cavallera A., et al. Pseudocysts in acute nonalcoholic pancreatitis - Incidence and natural history. Dig Dis Sci 1999; 44:1669-73.
-
4.
Lumsden A., Bradley E.L. 3d. Secondary pancreatic infection. Surg Gynecol Obstet 1990; 170:459-67.
-
5.
Berger H.G., Rau B., Mayer J., Pralle U. Natural course of acute pancreatitis. World J Surg 1997; 21:130-5.
-
6.
Trinidad E.E., Ramirez-Ronda C.H., [Pancreatic abscess and infected pseudocyst] Article in Spanish. Bol Asoc Med P R 1994; 86:68-70.
-
7.
Kothaj P., Melus P., Marco L., Pelikan A. [Pancreatic abscesses] Article in Cczech. Bratisl Lek Listy 1995; 96:250-3.
-
8.
Fedorac I.J., Ko T.C., Djuricin G., McMahon M., Thrompson K., Prinz R.A. Secondary pancreatic infections: are they distinct clinical entities? Surgery 1992; 112:824-30.
-
9.
Delcenserie R., Dellion-Lozinguez M.P., Yzet T., et al. Pancreatic concentration of cefepime. J Antimicrob Chemother 2001; 47:711-13.
-
10.
O’Malley V.P., Cannon J.P., Postier R.G. Pancreatic pseudocysts: cause, therapy, and results. Am J Surg 1985; 150:680-2.
-
11.
Isenmann R., Beger H.G. Natural history of acute pancreatitis and the role of infection. Bailliere’s best practice & research 1999; 13:291-301.
-
12.
Baron T.H., Morgan D.E. Acute necrotizing pancreatitis. N Engl J Med 1999; 340:1412-7.
-
13.
Runzi M., Layer P., Buchler M.W., et al. [The therapy of acute pancreatitis. General guidelines]. Zeitschrift fur Gastroenterologie 2000; 38:571-81.
-
14.
Uhl W., Isenmann R., Buchler M.W. Infections complicating pancreatitis: diagnosing, treating, preventing. New horizons (Baltimore, Md 1998; 6 (2 Suppl):S72-9.
-
15.
Banks P.A., Freeman M.L. Practice guidelines in acute pancreatitis. Am J Gastroenter 2006; 101:2379-400.
-
16.
VanSonnenberg E., Wittich G.R., Casola G., et al. Percutaneous drainage of infected and noninfected pancreatic pseudocysts: experience in 101 cases. Radiology 1989; 170 (3 Pt 1):757-61.
-
17.
Frommeyer L., Bihl P., Schmidt-Wilcke H.A. [Iatrogenic Candida infection in pancreatic pseudocyst] Article in German. Gastroenterol 1991 Aug; 29(8):392-4.
-
18.
Boerman D., van Gulic T.M., Obertop H., Gouma D.J. Internal drainage of infected pancreatic pseudocysts: safe or sorry? Dig Surg 1999;16(6):501-5.
-
19.
Kolvenbach H., Hirner A. Infected pancreatic necrosis possibly due to combined percutaneous aspiration, cystogastric pseudocyst drainage and injection of a sclerosant. Endoscopy 1991; 2:102-105.
-
20.
Criano E., De Stefano A.A., Weiner T.M., Jaques P.f. Long term results of percutaneous catheter drainage of pancreatic pseudocysts. Surg Gynecol Obstet 1992; 4:293-298.
-
21.
Malecka-Panas E., Juszynski A., Chrzastek J., Nowacka B., Jarkowska J., Studniarek M. Pancreatic fluid collections: diagnostic and therapeutic implications of percutaneous drainage guided by ultrasound. Hepatogastroenter 1998; 45:873-8.
-
22.
Yung-Fang Chen, Hsein-Jar Chiang, Jeng-Her Chang. Abdominal fluid collection secondary to acute pancreatitis: treated with percutaneous catheter drainage. Chin Med J 1997; 60:265-72.
-
23.
Delcenserie R., Dellion-Lozinguez M.P., Yzet T., Leponite B., Hary L., Badoui R., et.al. Pancreatic concentration of cefepime. J Antimicrob Chemother 2001; 47:711-3.
-
24.
Mandell G.L., Bennett J.E., Dolin R., editors. Principles and Practice of Infectious Diseases. 7th ed. USA: Churchill Livingstone; 2010:1045-54.
-
25.
Singer M.V., Forssmann K. [Non-surgical therapy of pancreatitis complications (pseudocyst, abscesses, stenoses)] Schweiz Rundsch Med Prax 1994;83:865-9.
-
26.
Gerzof S.G., Johnson W.C., Robbins A.H., Spechlrer S.J., Nabseth D.C. Arch Surg 1984;119:888-93.
-
27.
G. Gopal Rao, A. Steiger. Linesolid levels in pancreatic abscess. Clin Microbiol Infection, Vol.7,Supp.1,2001,269.
-
28.
Takhtani D., Gupta S., Suman K., Kakkar N., Challa S., Wig J.D., Suri S. Radiology of pancreatic tuberculosis: a report of three cases. Am J Gastroenterol 1996; 91:1832-4.
-
29.
Lutwick L.I. Pancreatic abscess with Haemophilus influenzae and Eikenella corrodens. JAMA 1976; 236:2091-2.
-
30.
Ljubicic N., Bilic A. Inflamed pancreatic pseudocysts: optimization of pseudocysts fluid culture technique. Z Gastroenterol 1993; 3:198-200.
-
31.
Bu¨chler M., Malfertheiner P., Friess H., et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992; 103:1902-8.
-
32.
Adam U., Herms S., Werner U., et al. The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing pancreatitis. Infection 2001; 29:326-31.
-
33.
Gloor B., Müller C.A., Worni M., et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001; 136:592-6.
-
34.
Beger H.G., Rau B., Isenmann R., et al. Antibiotic prophylaxis in severe acute pancreatitis. Pancreatology 2005; 5:10-9.
-
35.
Siefert H.M., Kohlsdorfer C., Steinke W., et al. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. J Antimicrob Chemother 1999; 43(Suppl B):61-7.
-
36.
Wacke R., Park S., Mundkowski R.G., et al. The penetration of moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis. Chemotherapy 2003; 49: 167-71.
-
37.
Wacke R., Förster S., Adam U., et al. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. J Antimicrob Chemother 2006; 58:994-9.